Related Experiment Video

Updated: May 23, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Selective killing of p53-deficient cancer cells by SP600125

Mohamed Jemaà1, Ilio Vitale, Oliver Kepp

  • 1INSERM, U848, Villejuif, France.

EMBO Molecular Medicine
|March 23, 2012
PubMed

Insights

The kinase inhibitor SP600125 preferentially kills p53-deficient cancer cells by inducing polyploidization and mitotic catastrophe. This occurs because p53-deficient cells cannot arrest their cell cycle, leading to cell death.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • TP53 gene inactivation is common in human cancers.
  • p53-deficient cells exhibit distinct responses to cellular stress.

Purpose of the Study:

  • To investigate the differential effects of SP600125 on p53-proficient and p53-deficient cancer cells.
  • To elucidate the mechanisms underlying SP600125-induced cytotoxicity in p53-deficient cells.

Main Methods:

  • High-content videomicroscopy of TP53(+/+) and TP53(-/-) human colon carcinoma cells.
  • In vitro and in vivo (xenograft) studies in mice.
  • Analysis of cell cycle progression, polyploidization, apoptosis, and MPS1 kinase activity.

Main Results:

  • SP600125 demonstrated preferential cytotoxicity against p53-deficient cancer cells.
  • p53-deficient cells failed to arrest cell cycle, leading to polyploidization and mitochondrial apoptosis upon SP600125 treatment.
  • Targeting MPS1 with SP600125 induced a polyploidization program that resulted in mitotic catastrophe in p53-deficient cells.

Conclusions:

  • SP600125 effectively targets p53-deficient cancers through a mechanism involving MPS1 and mitotic catastrophe.
  • The findings highlight a potential therapeutic strategy exploiting p53 deficiency for cancer treatment.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...